Advertisement

Mycosis fungoides

  • W. Sterry
Part of the Current Topics in Pathology book series (CT PATHOLOGY, volume 74)

Abstract

Mycosis fungoides is a T-cell lymphoma of low grade malignancy that most probably originates in the skin; it was described in France by Alibert as early as 1806. The skin changes are characterized by a sequence beginning with ecze-matous patches that develop into infiltrated plaques and terminate in ulcerating tumours; its natural course ranges from 10 to 15 years. Mycosis fungoides affects predominantly elderly people with a slight male preponderance. Although the term chosen by Alibert clearly is ethymologically and aetiologically a misnomer, it was rapidly accepted and is still used today.

Keywords

Mycosis Fungoides Sezary Syndrome Dermal Infiltrate Mycosis Fungoides Patient Convoluted Nucleus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aberer W, Schuler G, Stingl G, Hönigsmann H, Wolff K (1981) Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol 76:202–210PubMedGoogle Scholar
  2. Ablin RJ, Morris AJ (1973) Thymus-specific antigens on thymic derived lymphocytes. Transplantation 15:415PubMedGoogle Scholar
  3. Ackerman AB, Miller RC, Shapiro L (1966) Pustular mycosis fungoides. Arch Dermatol 93:221–225PubMedGoogle Scholar
  4. Ackerman AB, Breza TS, Capland L (1974) Spongiotic simulants of mycosis fungoides. Arch Dermatol 109:218–220PubMedGoogle Scholar
  5. Alibert JLM (1806) Description des maladies de la peau observées à l’Hopital St. Louis. Barrois l’aine’ et Fils, ParisGoogle Scholar
  6. Altmeyer P (1981) Disseminierte pagetoide Retikulose? Mycosis fungoides? Z Hautkr 56:63–74PubMedGoogle Scholar
  7. Asbell SO, Gadol N, Saluk P, Vonderheid EC, Brady LW (1978) Antibody-dependent cellular cyto-toxicity in patients with mycosis fungoides and Sézary syndrome. Int J Radiat Oncol Biol Phys 4:609–613PubMedGoogle Scholar
  8. Bast C de, Moriame N, Wanet J, Ledoux M, Achten G, Kenis Y (1971) Bleomycin in mycosis fungoides and reticulum cell lymphoma. Arch Derm 104:508–512PubMedGoogle Scholar
  9. Bazin E (1870) Lecons sur le traitment de maladies chroniques en general affections de la peau en particulier par l’emploi compare des eaux minérales de l’hydrothérapie et des moyens pharmaceutiques. Adrein Delahaye, Paris, p 425Google Scholar
  10. Berger CL, Morrison S, Chu AC, Patterson J, Estabrook A, Takezak S, Sharon J, Warburton D, Irigoyen O, Edelson RL (1982) Diagnosis of cutaneous T cell lymphoma by use of monoclonal antibodies reactive with tumor-associated antigens. J Clin Invest 70:1205–1215PubMedGoogle Scholar
  11. Bernardou A (1972) Bleomycin in the reticuloses. Br Med J 285–286Google Scholar
  12. Bernstein ID, Tarn MR, Nowinski RC (1980) Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen. Science 207:68–71PubMedGoogle Scholar
  13. Besnier E, Hallopeau H (1892) On the erythrodermia of mycosis fungoides. J Cutan Genitourin Dis 10:453Google Scholar
  14. Biddison WE, Rao PE, Talle MA, Goldstein G, Shaw S (1984) Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens. J Exp Med 159:783–797PubMedGoogle Scholar
  15. Bluefarb SM (1955) Is mycosis fungoides an entity? Arch Dermatol 71:293–302Google Scholar
  16. Bodensteiner DC, Skikne B (1982) Central nervous system involvement in mycosis fungoides. Diagnosis, treatment and literature review. Cancer 50:1181–1184PubMedGoogle Scholar
  17. Bonneau H, Cosarini J-P (1967) Etude ultrastructurale d’un cas de mycosis fungoides. Bull Soc Fr Dermatol Syphil 74:612–617Google Scholar
  18. Braathen LR, Førre Ø, Natvig J (1979) An antihuman T-lymphocyte antiserum: in situ identification of T cells in the skin of delayed-type hypersensitivity reaction, chronic photosensitivity dermatitis and mycosis fungoides. Clin Immun Immunopath 13:211–219PubMedGoogle Scholar
  19. Braun-Falco O, Burg G, Schmoeckel C (1981) Recent advances in cutaneous lymphoma. Clin Exp Dermatol 6:89–109PubMedGoogle Scholar
  20. Breathnach SM, McKee PH, Smith NP (1982) Hypopigmented mycosis fungoides: report of five cases with ultrastructural observations. Brit J Dermatol 106:643–649Google Scholar
  21. Brehm G (1974) Verhalten vom Immunglobulin E bei ausgewählten Dermatosen. Arch Derm Forsch 248:329–337Google Scholar
  22. Broder S, Bunn PA (1980) Cutaneous T-cell lymphomas. Semin Oncol 7:310–331PubMedGoogle Scholar
  23. Brownlee TR, Murad TM (1970) Ultrastructure of mycosis fungoides. Cancer 26:686–698PubMedGoogle Scholar
  24. Bryant E, Ronau SG, Iossifides IA (1982) Plasma cell myeloma in a patient with a cutaneous T-cell lymphoma. Cancer 50:2122–2125PubMedGoogle Scholar
  25. Büchner S, Rufli T (1979) Manifestation eines malignen Lymphoms von hohem Malignitätsgrad im Spätstadium der Mycosis fungodes. Enzymzytochemische und immunzytologische Untersuchungen. Dermatologica 159:125–131PubMedGoogle Scholar
  26. Bunn PA, Lamberg SI (1979) Report of the committee von staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep 63:725–728PubMedGoogle Scholar
  27. Bunn PA, Huberman MS, Whang-Peng J, Schlechter GP, Guccion JG, Matthews MJ, Gazdar AF, Dunnick NR, Fischmann AB, Ihde DC, Cohen MH, Fossieck B, Minna JD (1980) Prospective staging evaluation of patients with cutaneous T-cell lymphomas. Ann Int Med 93:223–230PubMedGoogle Scholar
  28. Bunn PA, Whang-Peng J, Carney DN, Schlam ML, Knutsen T, Gazdar AF (1980) DNA content analysis by flow cytometry and cytogenetic analysis in mycosis fungoides and Sézary syndrome. J Clin Invest 65:1440–1448PubMedGoogle Scholar
  29. Burg G, Braun-Falco O (1975) T- and B-Lymphozyten in Hautveränderungen kutaner Lymphome. Dtsch med Wschr 100:2562–2564PubMedGoogle Scholar
  30. Burg G, Rodt H, Grosse-Wilde H, Braun-Falco O (1978) Surface markers and mitogen response of cells harvested from cutaneous infiltrates in mycosis fungoides and Sézary’s syndrome. J Invest Dermatol 70:257–259PubMedGoogle Scholar
  31. Calabresi P, Parks RE (1980) Antiproliferative agents and drugs used for immunosuppression. In: The Pharmacological Basis of Therapeutics. Edited by Gilman AG, Goodmann LS, Gilman A. New York, Macmillan 1980, pp 1256–1313Google Scholar
  32. Cameron OJ (1933) Mycosis fungoides in mother and in daughter. Arch Dermatol Syphilol 27:232–236Google Scholar
  33. Camisa C, Goldstein A (1981) Mycosis fungoides. Small bowel involvement complicated by perforation and peritonitis. Arch Dermatol 117:234–237PubMedGoogle Scholar
  34. Cassuto JP, Kövary PM, Campagni JP, Simoney J, Maiolini R, Schneider M (1981) Mycosis fungoides associated with mediterranean lymphoma. Arch Dermatol Res 270:17–23PubMedGoogle Scholar
  35. Castellino RA, Hoppe RT, Blank N, Young ST, Fuks Z (1979) Experience with lymphography in patients with mycosis fungoides. Cancer Treat Rep 63:581–586PubMedGoogle Scholar
  36. Caya JG, Choi H, Tieu TM, Wollenberg NJ, Almagro UA (1984) Hodgkin’s disease followed by mycosis fungoides in the same patient. Cancer 53:463–467PubMedGoogle Scholar
  37. Chu AC, MacDonald DM (1979) Identification in situ of T lymphocytes in dermal and epidermal infiltrates of mycosis fungoides. Br J Dermatol 100:177–189PubMedGoogle Scholar
  38. Chu AC, Morgan EW, MacDonald DM (1980) Ultrastructural identification of T lymphocytes in tissue sections of mycosis fungoides. J Invest Dermatol 74:17–20PubMedGoogle Scholar
  39. Chu AC, Berger CL, Kung P, Edelson RL (1982a) In situ identification of Langerhans’ cells in the dermal infiltrate of cutaneous T-cell lymphoma. J Am Acad Dermatol 6:350–354Google Scholar
  40. Chu AC, Berger CL, Lynfield Y, Esseessee I, Edelson RL (1982b) Pathogenesis of cutaneous T cell lymphoma. In: Lymphoproliferative disorders of the skin. Ed Goos M, Christophers E, pp 57–64, Springer Berlin-Heidelberg-New YorkGoogle Scholar
  41. Chu AC, Patterson J, Berger C, Edelson R (1982c) T-cell subpopulations of cutaneous T-cell lymphoma (CTCL). J Invest Dermatol 78:334Google Scholar
  42. Chu AC, Patterson J, Goldstein G, Berger C, Takezaki S, Edelson RL (1982d) Thymopoietin-like substance in human skin. J Invest Dermatol 78:330Google Scholar
  43. Chu AC, Berger CL, Edelson RL, Spittle M, Russell C, Smith N (1983a) Circulating T cells in cutaneous T-cell lymphoma – a study using monoclonal antibodies against normal and malignant T cells. Br J Dermatol 108:219–246Google Scholar
  44. Chu AC, Robinson D, Catovsky D, Smith N (1983b) The Sézary cell – a phenotypic study in different dermatoses. 10th SCUR Annual meeting and 4th International Dermatopathology Colloquium, Berlin, 15.–18.7.83. Booklet of Abstracts, pp 31–32Google Scholar
  45. Civatte J, Kapetis E (1977) Problems in histological diagnosis of mycosis fungoides. Bull Cancer 64:187–190PubMedGoogle Scholar
  46. Claudy A, Schmitt D, Alario A, Brochier J, Perrot H, Thivolet J (1977) Immunocytological characterization of the mycosis fungoides tumour cells. Bull Cancer 64:241–248PubMedGoogle Scholar
  47. Claudy AL, Delomier Y, Hermier C (1982) Treatment of cutaneous T-cell lymphoma with a new aromatic retinoid (Ro 10-9359). Arch Dermatol Res 273:37–42PubMedGoogle Scholar
  48. Claudy AL, Rouchouse B, Boucheron S, Le Petit JC (1983) Treatment of cutaneous T-cell lymphoma with etretinate. Br J Dermatol 109:49–59PubMedGoogle Scholar
  49. Cohen SR, Stenn KS, Braverman IM, Beck GJ (1980) Mycosis fungoides: clinicopathologic relationships, survival, and therapy in 59 patients with observations on occupation as a new prognostic factor. Cancer 46:2654–2666PubMedGoogle Scholar
  50. Coleman CN, Williams CJ, Flint A (1977) Hématologic neoplasia in patients treated for Hodgkin’s disease. N Engl J Med 297:1249–1252PubMedGoogle Scholar
  51. Cooperrider PA, Roenigk HH (1978) Selective immunological evaluation of mycosis fungoides. Arch Dermatol 114:207–212PubMedGoogle Scholar
  52. Cyr DP, Geokas MC, Worsley GH (1966) Mycosis fungoides. Hématologic findings and terminal course. Arch Dermatol 94:558–572PubMedGoogle Scholar
  53. Daul CB, De Shazo RD (1983) AIDS: an update and interpretation. Ann Allergy 51:351–361PubMedGoogle Scholar
  54. David M, Shohat B, Hazar B, Feuerman EJ, Joshua H (1980) Identification of T- und B lymphocytes on skin sections from patients with lymphoproliferative disorders of the skin. J Invest Dermatol 75:491–494PubMedGoogle Scholar
  55. David M, Shohat B, Trainin N, Feuerman E (1980) Cell-mediated immunity in patients with mycosis fungoides in clinical remission. Cancer 46:41–44PubMedGoogle Scholar
  56. Davis BH, Simpkins H (1982) Mycosis fungoides and Sézary syndrome: malignant cells with T-cell enzymatic properties. Lab Invest 40:251Google Scholar
  57. Dobozy A, Hunydi J, Husz S, Kenderessy AS, Simon N (1977) Autoimmune anti-T cell antibodies in the sera of patients with mycosis fungoides. Brit J Dermatol 97:543–546Google Scholar
  58. Edelson RL (1979) Cutaneous T cell lymphoma. In: Moschella S (ed) Dermatology update, pp 195–207. Elsevier Press New YorkGoogle Scholar
  59. Edelson RL (1980) Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants. J Am Acad Dermatol 2:89–106PubMedGoogle Scholar
  60. Edelson RL, Kirkpatrick CH, Shevach EM, Schein PS, Smith RW, Green I, Lutzner M (1974) Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes. Ann Int Med 80:685–692PubMedGoogle Scholar
  61. Edelson RL, Berger CL, Raafat J, Warburton D (1979) Karyotype studies of cutaneous T cell lymphoma: evidence for clonal origin. J Invest Dermatol 73:548–550PubMedGoogle Scholar
  62. Epstein EH, Levin DL, Croft JD Jr, Lutzner MA (1972) Mycosis fungoides: survival, prognostic features, response to therapy and autopsy findings. Medicine 15:61–72Google Scholar
  63. Erkman-Balis B, Rappaport H (1974) Cytogenetic studies in mycosis fungoides. Cancer 34:626–633PubMedGoogle Scholar
  64. Farber EM, Zackheim HS, McClintock RP, Cox AJ (1968) Treatment of mycosis fungoides with various strengths of fluocinolone acetonide cream. Arch Dermatol 97:165–168PubMedGoogle Scholar
  65. Fischer ER, Branimir LH, Wechsler HL (1972) Ultrastructural features of mycosis fungoides. Amer J Clin Path 58:99–110Google Scholar
  66. Fischer T, Skogh M (1979) Treatment of parapsoriasis en plaques, mycosis fungoides, and Sézary’s syndrom with trioxalen baths followed by ultraviolet light. Acta Dermatovenerol 59:171–173Google Scholar
  67. Fischer T, van Vloten WA, Volden G (1978) Internal dissemination of mycosis fungoides despite successful local therapy. Acta Dermatovener 58:88–89Google Scholar
  68. Fischmann AB, Bunn PA Jr, Guccion JG, Matthews MJ, Minna JD (1979) Exposure to chemicals, physical agents, and biologic agents in mycosis fungoides and the Sézary syndrome. Cancer Treat Rep 63:591–596PubMedGoogle Scholar
  69. Flaxman BA, Zelazny G, van Scott EJ (1971) Nonspecificity of characteristic cells in mycosis fungoides. Arch Dermatol 104:141–147PubMedGoogle Scholar
  70. Flaxman BA, Sosis AC, van Scott EJ (1973) Changes in melanosome distribution in caucasoid skin following topical application of nitrogen mustard. J Invest Dermatol 60:321–326Google Scholar
  71. Focan C, Cryns-Lenain E, Bouhy F, Lapière C (1982) Clinical and histological staging as prognostic determinants in advanced cutaneous T cell lymphomas treated by sequential polychemotherapy with bleomycin, vinblastine and prednisone. Dermatologica 165:141–144PubMedGoogle Scholar
  72. Fuks ZY, Bagshaw MA, Farber EM (1973) Prognostic signs and the management of the mycosis fungoides. Cancer 32:1385–1395PubMedGoogle Scholar
  73. Fuks ZY, Castellino RA, Carmel JA, Farber EM, Bagshaw MA (1974) Lymphography in mycosis fungoides. Cancer 34:106–112PubMedGoogle Scholar
  74. Fukuhara S, Rowley JD, Variakojis D (1978) Banding studies of chromosomes in a patient with mycosis fungoides. Cancer 42:2262–2268PubMedGoogle Scholar
  75. Gahlen-Schulte S, Sterry W, Runne U (1982) Generalisierter Herpes simplex bei Mycosis fungoides (Ekzema herpeticum seu herpeticatum, Kaposi’s varizelliforme Eruption). Z Hautkr 57:1757–1765PubMedGoogle Scholar
  76. Gauge RW, Jones EW (1978) Kaposi’s sarcoma and immunosuppressive therapy: an appraisal. Clin exp Dermatol 3:135–146Google Scholar
  77. Gerdes J, Schwab U, Lemke H, Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13–20PubMedGoogle Scholar
  78. Gerdes J, Dallenbach F, Lennert K, Lemke H, Stein H (in press a) Proliferation rate in malignant non Hodgkin’s lymphomas as determined in situ with the monoclonal antibody Ki 67. Haematol OncolGoogle Scholar
  79. Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U, Stein H (in press b) Cell cycle analysis of a cell proliferation associated nuclear antigen defined by the monoclonal antibody Ki 67. J ImmunolGoogle Scholar
  80. Gilchrest BA, Parrish JA, Tauenbaum L, Haynes HA, Fitzpatrick TB (1976) Oral methoxalen photo-chemotherapy of mycosis fungoides. Cancer 38:683–689PubMedGoogle Scholar
  81. Glück S, Merck H, Sterry W, Goerz G, Schneider W (1983) Erhöhte Adenosin-Desaminase-Aktivität bei Patienten mit Mycosis fungoides. Hautarzt 34(Suppl. VI):337–338Google Scholar
  82. Goldgeier MH, Cohen SR, Braverman IM, Stenn KS (1981) An unusual and fatal case of disseminated cutaneous herpes simplex. J Am Acad Dermatol 4:176–180PubMedGoogle Scholar
  83. Goos M (1976) T-cell specific microenvironment in mycosis fungoides. Arch Dermatol Res 255:215–218PubMedGoogle Scholar
  84. Green SB, Byar DP, Lamberg SI (1981) Prognostic variables in mycosis fungoides. Cancer 47:2671–2677PubMedGoogle Scholar
  85. Greene MH, Dalager NA, Lamberg SI, Argyropoulos CE, Fraumeni JF Jr (1979) Mycosis fungoides: epidemiologic observations. Cancer Treat Rep 63:597–606PubMedGoogle Scholar
  86. Griem ML, Moran EM, Ferguson DS, Mettler FA, Griem SF (1975) Staging procedures in mycosis fungoides. Br J Cancer (Suppl.) 31:362–367Google Scholar
  87. Grossi CE, Webb SR, Zicca A, Lydyard PM, Moretta L, Mingardi MC, Cooper MD (1978) Morphological and histochemical analysis of two human T-cell subpopulations bearing receptors for IgM and IgG. J exp Med 147:1405–1417PubMedGoogle Scholar
  88. Groth O, Molin L, Thomsen K (1979) Tumor stage of mycosis fungoides treated with bleomycin and methotrexate : report from the Scandinavian mycosis fungoides study group. Acta Dermato-vener 59:59–63Google Scholar
  89. Hagedorn M, Kiefer G (1977) DNA content of mycosis fungoides cells. Arch Derm Res 258:127–134Google Scholar
  90. Hamminga L, Hermans J, Noordijk EM, Meijer CJLM, Scheffer E, van Vloten WA (1982a) Cutaneous T-cell lymphoma: clinicopathological relationships, therapy and survival in ninety-two patients. Br J Dermatol 107:145–156Google Scholar
  91. Hamminga L, Leigh PC, Blussé van oud Alblas A, van Vloten WA, van Furth R (1982b) Functions of peripheral-blood monocytes and granulocytes in cutaneous T-cell lymphoma. Br J Dermatol 107:157–164Google Scholar
  92. Hamminga B, Noordijk EM, van Vloten WA (1982c) Treatment of mycosis fungoides. Total-skin electron-beam irradiation vs topical mechlorethamine therapy. Arch Dermatol 118:150–153Google Scholar
  93. Haserick JR, Richardson JR, Grant DJ (1959) Remission of lesions in mycosis fungoides following topical application of nitrogen mustard. Cleve Clin R 26:144–147Google Scholar
  94. Haynes BF, Hensley LL, Jegasothy BV (1982a) Phenotypic characterization of skin infiltrating T-cells in cutaneous T-cell lymphoma: comparison with benign cutaneous T-cell infiltrates. Blood 60:463–473Google Scholar
  95. Haynes BF, Hensley LL, Jegasothy BV (1982b) Differentiation of human T-lymphocytes : II Phenotypic differences in skin and blood malignant T-cells in cutaneous lymphoma. J Invest Dermatol 78:323–326Google Scholar
  96. Heid E, Desvaux J, Brändie I, Grosshans E (1976) Der Verlauf der Parapsoriasis en plaques (Brocq’sche Krankheit). Z Hautkr 52:658–662Google Scholar
  97. Herbst M, Müller R (1984) Ganz-Haut-Elektronentherapie der Mycosis fungoides und des Sézary-Syndroms. Hautarzt 35:16–21PubMedGoogle Scholar
  98. Hjortshoj A, Schmidt H (1977) Photochemotherapy of mycosis fungoides. Danish Med Bull 24:40–42PubMedGoogle Scholar
  99. Hodge L, Vella Briffa D, Warin AP, Gange RW, Bleeken S (1977) Photochemotherapy in mycosis fungoides. Br Med J 2:1257–1259PubMedGoogle Scholar
  100. Hofmann C, Burg G, Plewig G, Braun-Falco O (1977) Photochemotherapie kutaner Lymphome. Orale und lokale 8-MOP-UVA-Therapie. Dtsch Med Wschr 102:675–679PubMedGoogle Scholar
  101. Holden CA, Morgan EW, MacDonald DM (1982a) The cell population in the cutaneous infiltrate of mycosis fungoides: in situ studies using monoclonal antisera. Br J Dermatol 106:385–392Google Scholar
  102. Holden CA, Staughton RCD, Campbell MA, MacDonald DM (1982b) Differential loss of T-lympho-cyte markers in advanced cutaneous T-cell lymphoma. J Amer Acad Dermatol 6:507–513Google Scholar
  103. Hönigsmann H, Konrad K, Gschnait F, Wolff K (1976) Photochemotherapy of mycosis fungoides VIIth International Congress of Photobiology, Rome, Italy, 29. Aug.–3. Sept. 1976, Book of Abstracts, p 222Google Scholar
  104. Hubermann MS, Bunn PA Jr, Matthews MJ, Ihde DC, Gazdar AF, Cohen MH, Minna JD (1980) Hepatic involvement in the cutaneous T-cell lymphomas. Cancer 45:1683–1688Google Scholar
  105. Hundeiker M, Berger H, Petres J (1968) Mycosis fungoides nach Thorotrastanwendung mit Entwicklung zur Retikulumzellsarkomatose. Arch klin exp Forsch 232:56–65Google Scholar
  106. Hunziker T, Zala A, Krebs A (1983) Retinoid-orale Photochemotherapie (RePUVA) als Kombinationsbehandlung bei Mycosis fungoides. Dermatologica 166:165–168PubMedGoogle Scholar
  107. Ippolito F, Giacalone B (1982) Sur un cas de mycosis fungoide avec manifestations tumorales traité avec Ro 10-9359 (Tigason). Ann Dermatol Venerol 109:65–72Google Scholar
  108. Kerl H (1981) Das Sézary Syndrom. Zbl Haut Geschlkr 144:359–380Google Scholar
  109. Kerl H, Hödl S, Smolle J, Konrad K (1984) Klassifikation und Prognose kutaner T-Zell-Lymphome. Z Hautkr (in press)Google Scholar
  110. Klein D (1976) Staging procedures in mycosis fungoides. Proc Am Soc Clin Oncol 17:277Google Scholar
  111. Knoth W (1976) Reticulosen. Hautarzt Suppl 1:295Google Scholar
  112. Kragballe K, Herlin T, Ellegaard J (1983) Stimulation of monocyte-mediated, antibody-dependent cytotoxicity in mycosis fungoides. Arch Dermatol 119:203–206PubMedGoogle Scholar
  113. Kresbach H (1981) Kutane maligne Lymphome. Ältere Vorstellungen und neuere Konzepte. Münch med Wschr 35:1291–1296Google Scholar
  114. Kubba RK, Bailin PL, Roenigk HH (1979) Immunological evaluation in mycosis fungoides: Before and after PUVA therapy. Arch Dermatol 116:178–181Google Scholar
  115. Kubec K, Krtkova J (1971) Clinical experiences with cyclophosphamide in the treatment of two cases of mycosis fungoides. Cesk Dermatol 46:166–169PubMedGoogle Scholar
  116. Kufe D, Major P, Agarwal R, Reinherz E, Frei E (1980) Phase I-phase II trial of deoxycoformycin (DCF) in T cell malignancies. Proc Am Assoc Cancer Res 21:328Google Scholar
  117. Kummermehr J, Burg G (1982) Autoradiographic pattern of cell proliferation in cutaneous malignant lymphoma. In: Lymphoproliferative diseases of the skin. Eds. Goos M, Christophers E, pp 71–78 Springer Berlin-Heidelberg-New YorkGoogle Scholar
  118. Lamberg SI, Diamond EL, Lorincz AL, Caro WA, Rappaport H, Variakojis D, Block JB, Fuks ZY, van Scott EJ (1975) Mycosis fungoides cooperative study. Arch Dermatol 111:457–459Google Scholar
  119. Lamberg SI, Green SB, Byar DP, Block JB, Clendenning WE, Epstein EN, Fuks ZY, Golitz LE, Lorincz AL, Michel B (1979) Status report of 376 mycosis fungoides patients at 4 years — Mycosis fungoides cooperative group. Cancer Treat Rep 63:701–707PubMedGoogle Scholar
  120. Lange Wantzin G, Larsen JK, Christensen IJ, Bruun Rasmussen B, Thomsen K (1983) Aneuploidy in cutaneous T-cell lymphoma. Acta Derm Venerol 63:283–289PubMedGoogle Scholar
  121. Lawrence H (1969) Transfer factor. Advance Immunol 11:195–201Google Scholar
  122. Leavell UW, DeSimone P (1976) Combined chemotherapy (COP) in treatment of mycosis fungoides: report of four cases. South Med J 69:915–917PubMedGoogle Scholar
  123. Lee LA, Fritz KA, Golitz L, Weston WL (1982) Second cutaneous malignancies in patients with mycosis fungoides treated with topical nitrogen mustard. J Am Acad Dermatol 7:592–598Google Scholar
  124. Lee LA, Ryan SR, Huff JG, Schocket AL (1982) Lymphocytotoxic antibodies in mycosis fungoides are predominantly antisuppressor cell. J Invest Dermatol 78:337Google Scholar
  125. Lefeber WR, Robinson JK, Clendenning WE, Dunn JL, Colton T (1981) Attempts to enhance light microscopic diagnosis of cutaneous T cell lymphoma (mycosis fungoides). Arch Dermatol 117:408–411PubMedGoogle Scholar
  126. Lennert K (1978) Malignant lymphomas other than Hodgkin’s disease. Springer Verlag Berlin-Heidelberg-New York, pp 165–185Google Scholar
  127. Lever WH, Schaumburg-Lever G (1983) Histopathology of the skin. 6th edition. J.P. Lippincott Co, PhiladelphiaGoogle Scholar
  128. Levi JA, Wiernik PH (1975) Management of mycosis fungoides: Current status and future prospects. Medicine 54:73–88PubMedGoogle Scholar
  129. Lipa M, Kunynetz R, Pawlowski D, Kerbel G, Haberman H (1982) The occurence of mycosis fungoides in two patients with preexisting Hodgkin’s disease. Arch Dermatol 118:563–567PubMedGoogle Scholar
  130. Lischka G, Bohnert E, Bachtold G, Jung EG (1977) Effects of 8-methoxypsoralen (8-MOP) and UVA on human lymphocytes. J Invest Dermatol 68:245Google Scholar
  131. Lowe NJ, Cripps DJ, Dufton PA, Vickers FH (1979) Photochemotherapy for mycosis fungoides. A clinical and histological study. Arch Dermatol 115:50–53PubMedGoogle Scholar
  132. Luger TA, Stadler BM, Katz SI, Oppenheim JJ (1981) Epidermal cell (keratinocyte)-derived thymo-cyte-activating factor (ETAF). J Immunol 127:1493–1502PubMedGoogle Scholar
  133. Lutzner MA, Hobbs JW, Horwvath P (1971) Ultrastructure of abnormal cells in Sézary syndrome, mycosis fungoides, and parapsoriasis en plaques. Arch Dermatol 103:375–386PubMedGoogle Scholar
  134. Lutzner M, Edelson R, Schein P, Green I, Kirkpatrick C, Ahmed A (1975) Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides and related disorders. Ann Int Med 83:534–552PubMedGoogle Scholar
  135. MacKie RM (1981) Initial event in mycosis fungoides of the skin is viral infection of epidermal Langerhans cells. Lancet 2:283–285PubMedGoogle Scholar
  136. MacKie RM, Turbitt ML (1982) The use of a double-label immunoperoxidase monoclonal antibody technique in the investigation of patients with mycosis fungoides. Br J Dermatol 106:379–384PubMedGoogle Scholar
  137. MacKie R, Dick HM, De Sousa MB (1976a) HLA and mycosis fungoides. Lancet 1 (7970), 1179Google Scholar
  138. MacKie R, Sless FR, Cochran R, De Sousa M (1976b) Lymphocyte abnormalities in mycosis fun-goides. Br J Dermatol 94:173–178Google Scholar
  139. Mahrle G, Thiele B, Ippen H (1983) Chemotherapie kutaner T-Zell-Lymphome mit Arotinoid. Dtsch med Wschr 108:1753–1757PubMedGoogle Scholar
  140. Marmelzat WL (1963) Mycosis fungoides: local injections of triamcinolone. Calif Med 98:139–141PubMedGoogle Scholar
  141. McMillan EM, Beeman K, Wasik R, Everett MA (1982a) Demonstration of OKT6-reactive cells in mycosis fungoides. J Am Acad Dermatol 6:880–887Google Scholar
  142. McMillan EM, Wasik R, Beeman K, Everett MA (1982b) In situ immunologic phenotyping of mycosis fungoides. J Am Acad Dermatol 6:888–892Google Scholar
  143. McMillan EM, Wasik R, Jackson I, Peters S, Everett MA (1982c) OKT6-reactive cells in mycosis fungoides. J Cut Pathol 9:55–60Google Scholar
  144. McNutt NS, Crain WR (1981) Quantitative electron microscopic comparison of lymphocyte nuclear contours im mycosis fungoides and in benign infiltrates in skin. Cancer 47:698–709PubMedGoogle Scholar
  145. Meijer CJ, van Leeuwen AW, van der Loo EM, van der Putte LB, van Vloten WA (1977) Cerebriform (Sézary-like) mononuclear cells in healthy individuals: a morphologically distinct population of T cells. Relationship with mycosis fungoides and Sézary’s syndrome. Virch Arch Cell Pathol 25:95–104Google Scholar
  146. Meijer CJ, van der Loo E, van Vloten WA, Cornelisse J (1978) Early diagnosis of mycosis fungoides and Sézary’s syndrome by computer assisted morphometric analysis of lymphoid cells. J Invest Dermatol 70:234Google Scholar
  147. Meijer CJ, van der Loo EM, van Vloten WA, van der Velde EA, Scheffer E, Cornelisse CJ (1980) Early diagnosis of mycosis fungoides and Sézary’s syndrome by morphometric analysis of lymphoid cells in the skin. Cancer 45:2864–2871PubMedGoogle Scholar
  148. Miller RA, Levy R (1981) Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody. Lancet 1:226–230Google Scholar
  149. Molin L, Skogh M, Volden G (1978) Successful PUVA-treatment in the tumour stage of mycosis fungoides associated with the appearance of lesions in organs other than the skin. Acta Dermato-vener 58:189–190Google Scholar
  150. Molin L, Thomsen K, Volden G (1979) Mycosis fungoides plaque stage treated with topical nitrogen mustard with and without attempts at tolerance induction : report from the Scandinavian mycosis fungoides study group. Acta Dermatol 59:64–68Google Scholar
  151. Molin L, Thomsen K, Volden G, Groth O (1980) Photochemotherapy (PUVA) in the pretumour stage of mycosis fungoides: a report from the Scandinavian mycosis fungoides study group. Acta Dermatovenerol 61:47–51Google Scholar
  152. Molin L, Thomsen K, Volden G, Groth O (1981) Photochemotherapy (PUVA) in the tumour stage of mycoses fungoides: a report from the Scandinavian fungoides study group. Acta Dermatovenerol 61:52–54Google Scholar
  153. Moran EM, Walther JR, Arouson IK, Variakojis D (1977) Clinical significance of circulating Sézary cells in mycosis fungoides. Proc Am Soc Clin Oncol 18:276Google Scholar
  154. Mortazawi SAM, Oberste-Lehn H (1973) Lichtsensibilisatoren und ihre therapeutischen Fähigkeiten. Erste vorläufige Mitteilung. Z Hautkr 48:1–9Google Scholar
  155. Munson D, Bunn PA, Schechter GP (1982) Fc-Receptor-defined T-lymphocyte subpopulations in patients with cutaneous T-cell lymphoma. J Invest Dermatol 79:317–321PubMedGoogle Scholar
  156. Neilau BA, Vonderheid EC, O’Neill KJ (1983) Natural cell-mediated cytotoxicity in cutaneous T-cell lymphomas. J Invest Dermatol 81:176–178Google Scholar
  157. Nordqvist CB, Kinney PJ (1976) T and B cells and cell mediated immunity in mycosis fungoides. Cancer 37:714–721PubMedGoogle Scholar
  158. Nowell PC, Finan JB, Vonderheid EC (1982) Clonal characteristics of cutaneous T cell lymphomas: cytogenetic evidence from blood, lymph nodes, and skin. J Invest Derm 78:69–75PubMedGoogle Scholar
  159. Oberste-Lehn H (1980) Photochemotherapie der T-Zellen-Lymphome. Z Hautkr 55:1335–1339PubMedGoogle Scholar
  160. Olsen EA, Delzell E, Jegasothy BV (1984) Second malignancies in cutaneous T cell lymphoma. J Am Acad Dermatol 10:197–204PubMedGoogle Scholar
  161. Oseroff AR, Miller RA, Stratte PJ, Levy R (1982) Monoclonal anti-T cell antibody in the therapy of mycosis fungoides. J Invest Dermatol 78:337Google Scholar
  162. Patterson JAK, Edelson RL (1983) Interaction of T-lymphocytes with the epidermis: immunopatho-logical studies. J Cut Pathol 10:540–549Google Scholar
  163. Pautrier LM, Woringer F (1932) Note préliminaire sur un tableau histologique particulier de lésions ganglionnaires accompagnant des éruptions dermatologiques généralisées prurigineuses, de types cliniques différents. Bull Soc Francaise Dermatol Syphilol 39:947–967Google Scholar
  164. Payne CM, Nagle RB, Lynch PJ (1984) Quantitative electron microscopy in the diagnosis of mycosis fungoides. A simple analysis of lymphocytic nuclear convolutions. Arch Dermatol 120:63–75PubMedGoogle Scholar
  165. Pierard GE, Franchimont C, de la Brassinne TLE, Lapiere CM (1982) Proliferation rate of cutaneous T cell lymphomas in the skin — relationship with histologic pattern and cytology. In : Lymphoproli-ferative diseases of the skin. Eds. Goos M, Christophers E, pp 65–70. Springer Verlag Berlin-Heidelberg-New YorkGoogle Scholar
  166. Price NM, Mirkovich AM (1978) Lymphocytotoxicity in mycosis fungoides. Br J Derm 98:97–102Google Scholar
  167. Price NM, Constantine VS, Hoppe RT, Fuks ZY, Färber EM (1977) Topical mechlorethamine therapy for mycosis fungoides. Br J Dermatol 97:547–555PubMedGoogle Scholar
  168. Price NM, Fuks ZY, Hoffman TE (1977) Hyperkeratotic and verrucous features of mycosis fungoides. Arch Dermatol 113:57–60PubMedGoogle Scholar
  169. Price NM, Deneau DG, Hoppe RT (1982) The treatment of mycosis fungoides with ointment-based mechlorethamine. Arch Dermatol 118:234–237PubMedGoogle Scholar
  170. Price NM, Hoppe RT, Deneau DG (1983) Ointment-based mechlorethamine treatment for mycosis fungoides. Cancer 52:2214–2219PubMedGoogle Scholar
  171. Przybilla B, Burg G, Schmoeckel C, Braun-Falco O (1983) Treatment of cutaneous T-cell lymphomas with TP-5. Acta Dermatol Venerol 63:524–529Google Scholar
  172. Rappaport H, Thomas LB (1974) Mycosis fungoides: the pathology of extracutaneous involvement. Cancer 34:1198–1229PubMedGoogle Scholar
  173. Reinherz EL, Kung PC, Goldstein RH, Levey RH, Schlossman SF (1980) Discrete stages of human intrathymus differentiation : analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci USA 77:1588–1592PubMedGoogle Scholar
  174. Resnick L, Schleider-Kushner N, Horwitz SN, Frost P (1984) Remission of tumor-stage mycosis fungoides following intravenously administered acyclovir. JAMA 251:1571–1573PubMedGoogle Scholar
  175. Robb-Smith AHT (1944) The reticular tissue and the skin. Br J Dermatol 56:151–165Google Scholar
  176. Roenigk HH (1977) Photochemotherapy of mycosis fungoides. Arch Dermatol 113:1047PubMedGoogle Scholar
  177. Roenigk HH Jr, Castrovinci AJ (1971) Mycosis fungoides bullosa. Arch Dermatol 104:402–406PubMedGoogle Scholar
  178. Rosas-Uribe A, Variakojis D, Molnar Z, Rappaport H (1974) Mycosis fungoides: an ultrastructural study. Cancer 34:634–645Google Scholar
  179. Rowden G, Lewis MG (1976) Langerhans cells: involvement in the pathogenesis of mycosis fungoides. Br J Dermatol 95:665–672PubMedGoogle Scholar
  180. Ruffieux C, Stalder M, Tran-Thang C (1984) Mycosis fungoides et gammopathie monoclonale. Association fortuite ou causale. Dermatologica 168:170–174PubMedGoogle Scholar
  181. Rüssel Jones R, Chu AC (1981) Pagetoid reticulosis and solitary mycosis fungoides. Distinct clinico-pathological entities. J Cut Path 8:40–51Google Scholar
  182. Samman PD (1972) The natural history of parapsoriasis en plaques (chronic superficial dermatitis) and prereticulotic poikiloderma. Br J Dermatol 87:405–411PubMedGoogle Scholar
  183. Sanchez JL, Ackerman AB (1979) The patch stage of mycosis fungoides. Criteria for histologic diagnosis. Am J Dermatopathol 1:5–26PubMedGoogle Scholar
  184. Sandbank M, Katzenellenbogen I (1968) Mycosis fungoides of prolonged duration in siblings. Arch Dermatol 98:620–627PubMedGoogle Scholar
  185. Sauder DN, Carter C, Katz SI, Oppenheim JJ (1981) Epidermal cell production of thymocyte activating factor. Clin Research 29:285 AGoogle Scholar
  186. Sauder DN, Noonan FP, DeFabo EC, Katz SI (1983) Ultraviolet radiation inhibits alloantigen presentation by epidermal cells : partial reversal by the soluble epidermal cell product, epidermal cell-derived thymocyte-activating factor (ETAF). J Invest Dermatol 80:485–489PubMedGoogle Scholar
  187. Scheffer E, Meijer CJLM, van Vloten WA (1980) Dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides. Cancer 45:137–148PubMedGoogle Scholar
  188. Schein PS, MacDonald JS, Edelson R (1976) Cutaneous T-cell lymphoma. Cancer 38:1859–1861PubMedGoogle Scholar
  189. Schlaeger M (1980) Immunglobulin E bei kutanen Lymphomen und bei der Parapsoriasis en plaques (Brocq). Dermatologica 161:1–7PubMedGoogle Scholar
  190. Schmitt D, Thivolet J (1980) Lymphocyte-epidermis interactions in malignant epidermotropic lymphoma: I. Ultrastructural aspects. Acta Dermatovener 60:1–11Google Scholar
  191. Schmitt D, Alario A, Touraine JL, Claudy AL, Perrot H, Thivolet J (1977) Specific surface antigen of human B and T lymphocytes : the use in the ultrastructural identification of cells extracted from cutaneous infiltrations. J Cut Pathol 4:211–235Google Scholar
  192. Schmitt D, Souteyrand P, Brochier J, Czernieliwski J, Thivolet J (1982) Phenotype of cells involved in mycosis fungoides and Sézary syndrome (blood and skin lesions) : Immunomorphological study with monoclonal antibodies. Acta Dermatovenerol 62:193–199Google Scholar
  193. Schmoeckel C, Burg G, Braun-Falco O (1979) Quantitative analysis of lymphoid cells in mycosis fungoides, Sézary’s syndrome and parapsoriasis en plaques. Arch Dermatol Res 264:17–28PubMedGoogle Scholar
  194. Schocket AL, Huff JC, Carr RI, Norris DA (1982) Humoral immunity in stage I mycosis fungoides: an increased incidence of lymphocytotoxic antibodies. Br J Dermatol 107:285–291PubMedGoogle Scholar
  195. Schuppli R (1976) Is mycosis fungoides an “Immunoma”? Dermatologica 153:1–6PubMedGoogle Scholar
  196. Segal RJ, Watson W (1978) Kaposi’s varicelliforme eruption in mycosis fungoides. Arch Dermatol 114:1067–1069PubMedGoogle Scholar
  197. Shelley WB (1980) Familial mycosis fungoides revisited. Arch Dermatol 116:1177–1178PubMedGoogle Scholar
  198. Sipos K (1965) Painting treatment of nitrogen mustard in mycosis fungoides. Dermatologica 130:3–11PubMedGoogle Scholar
  199. Smith RW, Terry WD, Buell DN, Sell KW (1973) An antigenic marker for human thymic lymphocytes. J Immunol 110:884PubMedGoogle Scholar
  200. Souteyrand P, Thivolet J, Fulton R (1981) Treatment of parapsoriasis en plaques and mycosis fungoides with an oral aromatic retinoid (Ro 10-9359). In: Retinoids. Advances in basic research and therapy. Edited by Orfanos CE, Braun-Falco O, Farber EM, Grupper Ch, Polano MR, Schuppli R, pp 313–316. Springer-Verlag, Berlin-Heidelberg-New YorkGoogle Scholar
  201. Steigleder GK (1974) Die lymphoretikuläre Reaktion. Eine neue Theorie zur Entstehung der Lym-phoblastome (Immunoblastome). Z Hautkr 49:987–995PubMedGoogle Scholar
  202. Steigleder GK (1976) Benign and malignant proliferative response. Acta Dermatovener 56:33–41Google Scholar
  203. Steigleder GK (1978) Zur Pathogenese der kutanen malignen Lymphome und Pseudolymphome der Haut. Hautarzt Suppl III 29:31–33Google Scholar
  204. Sterry W, Feller AC (1984) Immunohistochemical phenotyping of cutaneous T-cell lymphomas. Arch Dermatol Res 276:258Google Scholar
  205. Sterry W, Pullmann H, Steigleder GK, Meisterernst E (1980a) Autoradiographic and enzyme cyto-chemical investigations in cutaneous lymphomas. Cell Tiss Kin 13:210Google Scholar
  206. Sterry W, Steigleder GK, Nikolai B (1980b) Elevated colchicine sensitivity of dermal lymphocytes in mycosis fungoides. Acta Dermatovener 60:257–259Google Scholar
  207. Sterry W, Steigleder GK, Pullmann H (1980c) In situ identification and enumeration of T lymphocytes in cutaneous T cell lymphomas by demonstration of granular activity of acid non-specific esterase. Br J Dermatol 103:67–72Google Scholar
  208. Sterry W, Pullmann H, Steigleder GK (1981a) Proliferation kinetics of the dermal infiltrate in cutaneous malignant lymphomas. Arch Dermatol Res 270:285–290Google Scholar
  209. Sterry W, Schulze HJ, Steigleder GK (1981b) Altered lymphocyte surface in mycosis fungoides. Arch Dermatol Res 270:249Google Scholar
  210. Sterry W, Schulze HJ, Steigleder GK (1981c) Veränderte Zelloberfläche der dermalen Lymphozyten bei Mycosis fungoides. – Eine rasterelektronenmikroskopische Untersuchung. Z Hautkr 56:498–508Google Scholar
  211. Sterry W, Steigleder GK, Goos M, Meisterernst E (1982) In situ identification and enumeration of helper T lymphocytes in cutaneous malignant lymphomas by dipeptidyl-peptidase IV (DPP IV). J Cut Pathol 9:119–120Google Scholar
  212. Sterry W, Jansen M, Haneberg F, Steigleder GK (1983) Saure Esterase und Dipeptidyl-Peptidase IV als Marker immunologischer Lymphozytenpopulationen. Acta histochemica 28:181–190PubMedGoogle Scholar
  213. Stingl G, Knapp W (1977) Characterization of neoplastic mononuclear cells on tissue sections. Hae-matol Blood Transfus 20:189–196Google Scholar
  214. Stingl G, Gazze-Stingl LA, Aberer W, Wolff K (1981) Antigen presentation by murine epidermal Langerhans cells and its alteration by ultraviolet B light. J Immunol 127:1707–1713PubMedGoogle Scholar
  215. Symmers D (1932) Mycosis fungoides as a clinical and pathological nonexistent. Arch Dermatol Syphil 25:1–5Google Scholar
  216. Thomas JA, Janossy G, Graham-Brown RAC, Kung PC, Goldstein G (1982) The relationship between T-lymphocyte subsets and la-like antigen-positive nonlymphoid cells in early stages of cutaneous T-cell lymphoma. J Invest Dermatol 78:169–176PubMedGoogle Scholar
  217. Tjernlund UM (1978) Epidermal expression of HLA-DR antigens in mycosis fungoides. Arch Derm Res 261:81–86PubMedGoogle Scholar
  218. Touraine JL, Touraine F, Kiszkiss DF, Choi YS, Good RA (1974) Heterologous specific antiserum for identification of human T lymphocytes. Clin Exp Immunol 16:503–520Google Scholar
  219. Tourbier H, Schultz-Ehrenburg U (1981) Etagenwechsel by Mycosis fungoides unter systemischer PUVA-Therapie. Z Hautkr 56:923–929PubMedGoogle Scholar
  220. Tronnier H, Loehning R (1974) About the current status of the methoxalen UV-A therapy in dermatology. Castellania 2:267–271Google Scholar
  221. United States Bureau of the Census (1963) In: US Census of population, 1960. Washington DC US Government Printing Office, Vol 1Google Scholar
  222. van Leeuwen AWFM, Meijer CJLM, De Man JCH (1975) T-cell membrane characteristics of mycosis cells in the skin and lymph node. J Invest Dermatol 65:367–369PubMedGoogle Scholar
  223. van Scott EJ, Kalmanson JD (1973) Complete remission of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2) : Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologie tolerance. Cancer 32:18–30PubMedGoogle Scholar
  224. van Vloten WA, van Duijn P, Schaberg A (1974) Cytodiagnostic use of Feulgen-DNA measurements in cell imprints from the skin of patientes with mycosis fungoides. Br J Dermatol 91:365–371PubMedGoogle Scholar
  225. van Vloten WA, Scheffer E, Meijer CJLM (1978) DNA cytophotometry of lymph nodes from patients with mycosis fungoides and Sézary’s syndrome. J Invest Dermatol 70:234Google Scholar
  226. van Vloten WA, Scheffer E, Meijer CJLM (1979) DNA-cytophotometry of lymph node imprints from patients with mycosis fungoides. J Invest Dermatol 73:275–279PubMedGoogle Scholar
  227. van Vloten WA, Pet EA, Geraedts JPM (1980) Chromosome studies in mycosis fungoides. Br J Dermatol 102:507–513PubMedGoogle Scholar
  228. van der Harst-Oostveen CJGR, van Vloten WA (1978) Delayed-type hypersensitivity in patients with mycosis fungoides. Dermatologica 157:129–135PubMedGoogle Scholar
  229. van der Loo EM, van Muijen GNP, van Vloten WA (1979) C-type virus-like particles specifically localized in Langerhans cells and related cells of skin and lymph nodes of patients with mycosis fungoides and Sézary syndrome. Virchows Arch B (Cell Pathol) 31:193–203Google Scholar
  230. van der Loo EM, van Vloten WA, Cornelisse CJ, Scheffer E, Meijer CJLM (1981) The relevance of morphometry in the differential diagnosis of cutaneous T cell lymphomas. Br J Dermatol 104:257–269PubMedGoogle Scholar
  231. van der Putte SCJ, van der Meer (1981) Mycosis fungoides : a morphological study. Clin exp Dermatol 6:57–76PubMedGoogle Scholar
  232. Variakojis D, Rosas-Uribe A, Rappaport H (1974) Mycosis fungoides — pathologic findings in staging laparotomies. Cancer 33:1589–1600PubMedGoogle Scholar
  233. Vidal E, Brocq L (1885) Étude sur le mycosis fungoide. Le France Medical 2:946, 957, 969, 983, 993, 1005, 1019, 1085Google Scholar
  234. Viver A du, Vollum DI (1980) Photochemotherapy and topical nitrogen mustard in the treatment of mycosis fungoides. Br J Dermatol 102:319–322Google Scholar
  235. Vivier A du, Vonderheid EC, van Scott EJ, Urbach F (1978) Mycosis fungoides, nitrogen mustard and skin cancer. Br J Dermatol 99:61–63Google Scholar
  236. Volc-Platzer B, Majdic O, Wolff K, Knapp W, Stingl (1984) la antigens on keratinocytes in diseased skin. Arch Dermatol Res 276:258–259Google Scholar
  237. Volden G (1980) A study of the photosensitive factor in relation to skin lesions of mycosis fungoides patients. Dermatologica 161:89–92PubMedGoogle Scholar
  238. Volden G, Thune PO (1977) Light sensitivity in mycosis fungoides. Br J Dermatol 97:279–284PubMedGoogle Scholar
  239. Vonderheid EC (1984) Topical mechlorethamine chemotherapy. Considerations on its use in mycosis fungoides. Int J Dermatol 23:180–186PubMedGoogle Scholar
  240. Vonderheid EC, van Voorst Vader PC (1980) Herpes Zoster-Varicella in cutaneous T-cell lymphomas. Arch Dermatol 116:408–412PubMedGoogle Scholar
  241. Vonderheid EC, van Scott EJ, Wallner PE, Johnson WC (1979) A ten year experience with topical mechlorethamine for mycosis fungoides : comparison with patients treated by total-skin electron-beam radiation therapy. Cancer Treat Rep 63:681–689PubMedGoogle Scholar
  242. Vonderheid EC, Milstein HJ, Thompson KR, Wu BC (1980) Chronic herpes simplex infection in cutaneous T-cell lymphomas. Arch Dermatol 116:1018–1022PubMedGoogle Scholar
  243. Wadell CC, Zubler MA, Gore WS (1982) Acute myeloblastic leukemia following chemotherapy for mycosis fungoides. Arch Dermatol 118:179–182Google Scholar
  244. Warin AP (1981) Photochemotherapy in the treatment of psoriasis and mycosis fungoides. Clin Exp Dermatol 6:651–657PubMedGoogle Scholar
  245. Weber G (1975) Blacklight-Meladinine : eine neue Dimension in der Dermatotherapie. Dtsch Ärzteblatt 72:1407–1410Google Scholar
  246. Whang-Peng J, Bunn PA, Knutsen T, Matthews MJ, Schechter G, Minna JD (1982) Clinical implications of cytogenetic studies in cutaneous T-cell lymphoma (CTCL). Cancer 50:1539–1553PubMedGoogle Scholar
  247. White SI, Marsden JR, Marks JM, Proctor S (1984) Autoimmune haematolytic anaemia occuring in a patient with mycosis fungoides. Br J Dermatol 110:495–497PubMedGoogle Scholar
  248. Wiklund D, Norris DA, Morris RJ, Sanderson RJ, Weston WL (1979) Monocyte function and subpopulation in mycosis fungoides. Clin Res 27:139AGoogle Scholar
  249. Willemze R, de Graff-Reitsma CB, Cnossen J, van Vloten WA, Meijer CJLM (1983) Characterization of T-cell lymphomas and benign inflammatory dermatoses. J Invest Dermatol 80:60–66PubMedGoogle Scholar
  250. Winkler CF, Bunn PA (1984) Combination chemotherapy in cutaneous lymphomas. In: Progress in diseases of the skin. Vol. 2. Ed. Fleischmajer R. Grune and Stratton. Orlando — San Diego – San Francisco – New York – London – Toronto – Montreal – Sydney – Tokyo – Sao Paulo, pp 185–215Google Scholar
  251. Wiskemann A (1980) Röntgentherapie der Haut. In: Dermatologie in Praxis und Klinik. Hrsg.: Korting GW, Thieme Verlag, Stuttgart, Bd 1, pp 734–749Google Scholar
  252. Wolf AF, Landes E (1984) Mycosis fungoides mit Beteiligung des Zentralnervensystems. Hautarzt 35:22–26PubMedGoogle Scholar
  253. Worm AM, Hastrup N, Hou-Jensen K, Thomsen K (1978) Bone marrow involvement in mycosis fungoides demonstrated by needle biopsy. J Cutan Pathol 5:31–34PubMedGoogle Scholar
  254. Yamamura T, Aozasa K, Sano S (1984) The cutaneous lymphomas with convoluted nuclei. J Am Acad Dermatol 10:796–803PubMedGoogle Scholar
  255. Yambe H, Ishii Y, Kikuchi K, Jimbow K (1981) E-rosette inhibitory factor in sera from patients with mycosis fungoides. J Invest Dermatol 76:376–380PubMedGoogle Scholar
  256. Yeckley JA, Weston WL, Thorne EG (1975) Production of Sézary-like cells from normal human lymphocytes. Arch Dermatol 111:29–32PubMedGoogle Scholar
  257. Zachariae H, Grunnet E, Ellegaard J, Thestrup-Pedersen K (1975) Transfer factor as an additional therapeutic agent in mycosis fungoides. Acta Allergol 30:272PubMedGoogle Scholar
  258. Zachariae H, Grunnet E, Thestrup-Pedersen K (1979) Transfer factor in mycosis fungoides: a case report on a patient “cured”. Acta Dermatovenerol 59:375–378Google Scholar
  259. Zachariae H, Grunnet E, Thestrup-Pedersen K, Molin L, Schmidt H, Starfelt F, Thomsen K (1982) Oral retinoid in combination with bleomycin, cyclophosphamid, prednisone and transfer factor in mycosis fungoides. Acta Dermatovenerol 62:162–164Google Scholar
  260. Zackheim HS, Epstein EH (1975) Treatment of mycosis fungoides with topical nitrosourea compounds. Arch Dermatol 111:1564–1570PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • W. Sterry

There are no affiliations available

Personalised recommendations